{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-142304","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.927853+00:00","generated_at":"2026-06-26T00:01:17.540767+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Definitive Healthcare Q1 revenue $50.1M (+36% YoY); CEO transition to Musslewhite in August","bullets":["Revenue $50.1M, +36% YoY; net loss ($13.1M) widened from ($10.5M); adjusted net income $7.7M (vs $2.6M).","Adjusted EBITDA $14.0M (28% of revenue) vs $14.1M (38%) in Q1 2021; cash from ops $13.6M.","Q2 2022 guidance: revenue $53-54M (+34%); full year revenue $220.5-224.5M (+33-35%).","Robert Musslewhite (President) appointed CEO effective Aug 1, 2022; founder Jason Krantz becomes Executive Chairman.","Musslewhite receives annual base salary $429k, RSU grants, and change-in-control benefits; Krantz retains reduced salary and equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-142304","json":"https://secwatch.observer/filing/0001193125-22-142304.json","markdown":"https://secwatch.observer/filing/0001193125-22-142304.md","text":"https://secwatch.observer/filing/0001193125-22-142304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/d329213d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:01:17.540767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"161b9c7252","claim":"Robert Musslewhite was appointed as Chief Executive Officer at Definitive Healthcare Corp..","evidence_excerpt":"On May 5, 2022, the Company announced that on May 3, 2022 its Board of Directors (the “Board”) appointed Robert Musslewhite, the Company’s current President, to the position of Chief Executive Officer (“CEO”), effective August 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"dbdecce4b3","claim":"Jason Krantz changed role as Executive Chairman at Definitive Healthcare Corp..","evidence_excerpt":"Effective on August 1, 2022, Jason Krantz, the Company’s founder, Chairman of the Board and current CEO will step down from his role as CEO, and become Executive Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down as CEO and became"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}